Exo (pronounced “echo”), a pioneering health information and medical devices company, today announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. By integrating Medo’s proprietary Sweep AITM technology into its ultrasound platform, Exo will make ultrasound imaging more accessible to a wider range of caregivers.